Support program for new leukodystrophy trials and patient partnerships
Pilot Core of the Global Leukodystrophy Initiative Clinical Trial Network (GLIA-CTN)
This program funds small pilot projects and patient-centered partnerships to speed better diagnosis, care, and treatments for people with leukodystrophies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11172783 on NIH RePORTER |
What this research studies
From a patient's view, this program provides yearly seed funding for short pilot projects and an annual career award to grow clinicians and researchers focused on leukodystrophies. It also supports two six-month advocacy partnership awards each year so patient groups can work directly with researchers on practical projects. Selected pilots are reviewed for alignment with shared data principles and to create preliminary data that can lead to future clinical trials. The goal is to improve diagnostic tools, clinical trial readiness, and collaboration between families, advocates, and clinical teams.
Who could benefit from this research
Good fit: People of any age with a diagnosed leukodystrophy (for example arylsulfatase A deficiency) and families active with leukodystrophy patient advocacy groups are the most likely to be invited to participate in related pilot activities.
Not a fit: People without leukodystrophies or those seeking immediate treatment rather than involvement in research planning or advocacy projects are unlikely to receive direct benefit from this program.
Why it matters
Potential benefit: If successful, this work could speed the development of better diagnostics and make it easier for people with leukodystrophies to join future clinical trials and access new treatments.
How similar studies have performed: Rare-disease trial networks and pilot funding programs have helped launch successful early trials and diagnostic advances, though targeted pilot efforts specifically for many leukodystrophies are still emerging.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Vanderver, Adeline Lucie — Children's Hosp of Philadelphia
- Study coordinator: Vanderver, Adeline Lucie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.